Meclizine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

H1 antagonist.

IndicationThis section has been translated automatically.

Nausea, vomiting, motion sickness, allergic diseases.

Dosage and method of useThis section has been translated automatically.

1-2 times/day 25 mg p.o. or 1-2 times 50 mg as a supplement.

Undesirable effectsThis section has been translated automatically.

Sedation, visual disturbances, dry mouth, gastrointestinal disorders, hypersensitivity reactions.

InteractionsThis section has been translated automatically.

Strengthening the effect of centrally attenuating drugs and alcohol.

ContraindicationThis section has been translated automatically.

Pregnancy, lactation, prostate hypertrophy, narrow-angle glaucoma.

PreparationsThis section has been translated automatically.

Post harbour, Peremesin

PatientinformationThis section has been translated automatically.

Remember! Patients should be advised of the limitation of their ability to react before starting therapy!

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer